Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

Details for Australian Patent Application No. 2007279261 (hide)

Owner Imclone Systems Incorporated

Inventors Rowinsky, Eric

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007279261

PCT Pub. Number WO2008/014386

Priority 60/833,487 27.07.06 US

Filing date 26 July 2007

Wipo publication date 31 January 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/014386 Priority application(s): WO2008/014386

13 August 2009 Alteration of Name

  The name of the applicant has been altered to ImClone LLC

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007279272-Method and system for producing metallic iron nuggets

2007279256-Modulators of chemokine receptor activity, crystalline forms and process